PE Tech Report


Like this article?

Sign up to our free newsletter

Palatine-backed tranScrip makes key acquisition

tranScrip, a fast-growing contract drug development organisation which supports the development and lifecycle of medicines, and a portfolio company of UK mid-market private equity investor Palatine, has acquired Dublin-based Real Regulatory, a highly respected business specialising in European regulatory affairs, quality systems and compliance for medical products.

The strategic acquisition expands tranScrip’s regulatory affairs capabilities, strengthening its ability to provide comprehensive support to its customers. The deal is the first acquisition made by tranScrip since it secured the backing of Palatine in 2021 via its dedicated Impact Fund.

Like this article? Sign up to our free newsletter